Jennifer Nason, global head of tech, media and telecom at JPMorgan, describes M&A trends in the space and what's ahead for the group. » Read More
Herbalife whipsawed after The New York Post reported the firm and the Federal Trade Commission settled a years-long probe.
The market's inertia is beginning to set milestones. What will break the fog of low-volume neutrality?
The SPDR Homebuilders ETF (XHB) tracked for its best day since March 1, when it gained 2.56 percent.
Shares of Autozone recovered from early losses Tuesday after the company reported quarterly profit and sales that missed Wall Street estimates.
Stocks appear increasingly comfortable with the idea of a summer interest rate rise.
Sam Zell said he's investing less today because he sees fewer opportunities and selling more because he doesn't get buyers' optimism.
Shares of Best Buy fell more than 5 percent after the electronics retailer said CFO Sharon McCollam will step down.
Shares of Archer-Daniels-Midland could be set to rally in the second half of the year, BMO Capital Markets predicts.
BMO just upgraded Deere to "outperform" from "market perform." Here's why.
"The Fed is not the wizard of Oz," Voya Investment Management's Karyn Cavanaugh says.
Some of the names on the move ahead of the open.
Cowen just upgraded Microsoft to "outperform" from "market perform." Here's why.
The bank has redefined itself in the wake of the global financial crisis, and Goldman Sachs feels fine.
In the hedge fund world, the rich are getting richer — but just barely.
According to some strategists, market volatility could stop the Fed from raising rates.
Best Buy forecast profit below analysts' estimates, partly due to a disruption in supply of some high-margin products after an earthquake in Japan.
Toll Brothers' revenue rose nearly 31 percent, as the company sold more luxury homes at higher prices, mainly in the West market and California.
Jim Cramer found five stocks hated in the S&P 500 with charts that could change investors' minds.
Jim Cramer discovered one off-the-radar medical play where money managers are stuffing cash.
Slow and steady stocks may be just the right investment in this market environment, as long as they are the right ones, two pros say.
Get the best of CNBC in your inbox